Andy is a Managing Director with Talu Ventures in Brisbane, Australia. Talu Ventures was founded in 2013 with a portfolio of investments formerly managed by CM Capital Investments. Andy joined CM Capital Investments in 2003 and spent 7 years as a Partner in the firm.
Andy has more than 20 years of experience in the biomedical and IT industries. Following 4 years as a Project Manager at the CSIRO, Andy spent 5 years at AGEN Biomedical in various project management and business development roles. He joined Lake Technology, Sydney, in 1999, prior to its ASX listing, as Director of Business Development & Licensing. Lake Technology was later acquired by Dolby Labs in 2003.
Andy is a current Board member of Universal Biosensors Pty (ASX : UBI), SpeeDx Pty, Advent Pharmaceuticals Pty, Altiris Pharmaceuticals Inc and Piedmont Pharmaceuticals Inc.
Andy has a BSc Hons degree in Physics from the University of St Andrews in Scotland. He also has a Master of Science degree in Instrumentation from the University of Manchester. Andy has a Diploma of Financial Services (Financial Markets) from AFMA and a post-grad Certificate in Science Media & Journalism from the University of Technology in Sydney.